Morning Trend | Karyopharm Therapeutics Major Activity, Is the Attack Window Coming?

Karyopharm Therapeutics (KPTI.US) has experienced a long period of consolidation at low levels, and yesterday there were finally signs of significant buying activity during the trading session, leading to a sudden increase in trading sentiment in the community. Many short-term players rushed to buy around the $1.45 level, collectively anticipating that the main upward wave would "come as expected." The market shows that KPTI's shares have been circulating repeatedly in the $1.42-$1.50 range, with increasing signs of heavy control by the main players. As long as it breaks through $1.53 and stabilizes with increased volume, the short-term space is likely to open up easily. It is important to note that there is considerable divergence, with some players clearly taking profits at high points, and the sustainability of the rise still needs to be observed based on the main players' willingness to add positions. From a technical indicator perspective, the characteristics of a rebound from an oversold condition are evident and still in the early stages; if supported by capital, it is very likely to lead to an accelerated market. There are no significant negative factors in the fundamentals, and the short-term trading logic purely looks at the chip structure and sector trends. The strategy during the trading session suggests lightly testing the highs while closely monitoring whether the main players' large orders continue to buy in; otherwise, there could be a sudden pullback after a spike. The community generally expects a turning point this week to be very close, and aggressive traders may try to enter and exit quickly while maintaining key support lines. The main players' behavior in KPTI has shown significant volatility, and short-term opportunities are present in this window period